Professional Documents
Culture Documents
Patient Assessment in Pharmacy Practice Third Edition Ebook PDF Version
Patient Assessment in Pharmacy Practice Third Edition Ebook PDF Version
Patient Assessment in Pharmacy Practice Third Edition Ebook PDF Version
system. This is not meant to be an all-inclusive discussion assessment skills. The activities are not meant to be all-in-
of these disease states but rather a basic overview. As a clusive, and instructors are encouraged to expand accord-
large part of patient assessment entails correlating signs ing to their particular learning environment.
and symptoms with possible diseases, we felt that a basic
foundational discussion was necessary.
■ System Assessment PEDAGOGICAL FEATURES
● Subjective Information: The primary skill that a phar- Nearly all chapters include numerous pedagogical features
macist uses in nearly all practice settings is communica- that enhance the book’s mission as a practical text that
tion or, more specifically, patient interviewing to obtain applies patient assessment skills to the pharmacy practice
the health and medication history (e.g., symptoms and setting.
medication utilization). The interviewing technique
(INTERVIEW) that we use is a combination of open- ■ Boxes and Tables:
ended questions as a starting point and then closed-ended Throughout each chapter, special boxes highlight consistent
questions to elicit more specific symptom data concerning categories of information from chapter to chapter. These
the particular symptom. The goal is to provide focused include:
direction to elucidate information relative to the specific ● Signs and Symptoms: list the most common subjective
disease states/symptoms discussed. and objective findings related to the primary disease
● Objective Information: Physical examination and lab/ states discussed in that chapter
diagnostic tests are discussed as objective information. ● Drug-Induced Symptoms: list drugs that may cause signs
The physical examination is covered using a step-by-step or symptoms discussed in that chapter
approach with each technique (T E C H N I Q U E ) to
allow the novice learner to be able to easily follow the ap- ● Causes of Disease: list common non–drug-related causes
propriate procedures. Normal findings are described with of diseases
the technique and abnormalities (ABNORMALITIES ) are ● General boxes: list content material that requires empha-
highlighted as a separate section after each technique. In sis but does not fit the previous categories
addition, specific cautions ( C A U T I O N ) are high- ● Tables are also used throughout the text to highlight
lighted to emphasize particular maneuvers that are sensi- important information that may be more challeng-
tive to error or misinterpretation of results. ing for the reader/student to understand in basic text
■ Application to Patient Symptoms: This section is de- format.
signed as patient cases to illustrate a practice situation in ■ Key Terms (boldface text) for each chapter are listed im-
which pharmacists use patient assessment skills. We have mediately prior to the Anatomy and Physiology Overview.
attempted to vary the practice settings in which these These terms are defined in text directly following each term
cases occur; however, the majority are in the community as well as in the glossary at the end of the book.
environment.
Each case includes:
● Patient–pharmacist initial interaction ART
● Interview questions with patient responses To illustrate the textbook, figures have been chosen that
● Objective assessment information pertinent to the pa- will assist the reader’s understanding of the patient assess-
tient situation ment process. Specifically, photographs are used in nearly all
chapters to illustrate physical examination techniques as well
● Discussion to assist the student in analysis/evaluation of
as abnormal findings. Line drawings are used to illustrate
the subjective and objective patient data (i.e., the patient
normal anatomy and physiology.
assessment process)
● Patient care plan provides examples of documentation
that should accompany patient-centered care activi- SPECIAL INCLUSIONS/EXCLUSIONS
ties. Documentation is required for all healthcare pro-
It was a challenge to the authors to decide how to approach
fessionals. However, pharmacists are relatively new in
the physical examination techniques in this text. As previously
documenting their patient care interactions. We chose
stated, this area of pharmacy practice is frequently limited.
the SOAP note approach because it is the most common
However, the role of the pharmacist is expanding. Collabora-
method of documentation used across all healthcare
tive drug therapy management is on the rise and, thus, the
professions.
role of the pharmacist in patient care and medication therapy
● Self-assessment and critical thinking questions to assist management is growing. In addition, schools and colleges of
the student in learning important information from the pharmacy take varied approaches when teaching this material
chapter. Answers to the self-assessment questions are in their curriculum. Therefore, we chose to include physical
provided at the end of the book. examination techniques that are commonly used in practice
■ Skill Development Activities: The activities listed at the today (e.g., blood pressure measurement) as well as tech-
end of the chapter are suggested for the instructor to use niques that may be used only in specialty practices today or
possibly in a skills lab environment to assist students in may provide future practice opportunities (e.g., auscultating
learning, practicing, and demonstrating practical patient breath sounds).
I t is my pleasure to recognize the many wonderful friends and colleagues who helped make
the revision of this textbook possible. For their encouragement, help, and support, I send my
gratitude.
To the pharmacy students at Creighton University, whose enthusiastic response and motivation
for learning were an inspiration. To the readers who took the time to write emails and letters of sup-
port, encouragement, and suggestions, your comments were gratefully received and were helpful.
To the reviewers who spent considerable time in reviewing the second edition, your suggestions and
ideas were critical to the changes and additions for the third edition.
To my friends and colleagues, who were a willing resource of information, constructive com-
ments, support, and encouragement. I am particularly grateful to Emily Knezevich, PharmD, BCPS,
CDE; Mikayla Spangler, PharmD, BCPS; Maryann Skrabal, PharmD, CDE; and Amy Haddad, RN,
PhD. To all the contributing authors who are listed at the beginning of each chapter, I extend my
thanks for their professional contribution to the content. To the pharmacy faculty and students who
reviewed the draft manuscripts and provided valuable feedback for revision, thank you.
To the tenacious team at Wolters Kluwer, who have the skills, expertise, and persistence to mold
our manuscript into a professional product. Their patience, assistance, and encouragement made
this book possible.
To the many patients and students with whom I have worked throughout the years—they are the
inspiration and source from which came many ideas for this book. It is my hope that future students
will apply the skills and principles of this text to enhance patient care within their future practice
environment.
Most importantly, I am grateful to my wonderful family. Their love and steadfast support and
encouragement kept me going throughout the revision process.
xi
xiii
xv
xvii
Chapter 1 Chapter 11
General Approach to Patient Assessment Videos: Approach Physical Examination Videos: Respiratory System
to Patient Centered Care for the Pharmacist Application Videos: Asthma Patient Assessment
Chapter 3 Chapter 12
General Approach to Patient Assessment Videos: Preparing Physical Examination Videos: Cardiovascular System
for History Taking Application Videos: Anticoagulation Patient Assessment
General Approach to Patient Assessment Videos: Health and
Chapter 13
Medication History
Physical Examination Videos: Peripheral Vascular System
Chapter 4 Application Videos: Anticoagulation Patient Assessment
General Approach to Patient Assessment Videos: Principles
Chapter 14
and Methods of Basic Physical Examination
Physical Examination Videos: Abdomen (GI, Hepatic, and
Physical Examination Videos: Introduction to Body System
Renal Systems)
Examination
Chapter 15
Chapter 5
Physical Examination Videos: Abdomen (GI, Hepatic, and
Physical Examination Videos: General Assessment and Vital
Renal Systems)
Signs
Application Videos: Hypertension Patient Assessment Chapter 16
Application Videos: Fever Patient Assessment Physical Examination Videos: Abdomen (GI, Hepatic, and
Renal Systems)
Chapter 8
Physical Examination Videos: Skin, Hair, and Nails Chapter 17
Application Videos: Poison Ivy Patient Assessment Physical Examination Videos: Musculoskeletal System
Chapter 9 Chapter 18
Physical Examination Videos: Eyes Physical Examination Videos: Nervous System
Physical Examination Videos: Ears Chapter 20
Chapter 10 Application Videos: Diabetes Patient Assessment
Physical Examination Videos: Head and Neck
OVERVIEW OF
PATIENT ASSESSMENT
GLOSSARY TERMS
◗ Drug therapy problem JB is a 74-year-old man who comes to the pharmacy for a refill of his
◗ Medication management services antihypertensive medication, lisinopril. As he approaches the phar-
◗ Patient assessment macy counter, he loses his balance slightly, but he catches himself on
the counter. The pharmacist asks, “Are you okay, Joe?” The patient
◗ Pharmaceutical care
answers, “Oh, yes, I’m fine. I just stumbled a little. I do that quite
◗ Pharmacotherapy workup often these days. I need a refill of my blood pressure medicine.” The
pharmacist pulls up Joe’s drug therapy profile on the computer screen
and asks, “What’s the name of the medication?” The patient answers,
“I need my lisinopril.”
In the real-life example of an interaction between a patient and a
pharmacist cited earlier, there exists an opportunity for the pharmacist
to either ignore the patient’s loss of balance and proceed with refilling
his lisinopril or the pharmacist can gather further patient information
(both subjective and objective); assess the data; and, possibly, iden-
tify, resolve, and even prevent a drug-related problem (or problems).
In other words, the pharmacist has the opportunity to put into prac-
tice the philosophy of patient-centered care, which is the key com-
ponent of pharmaceutical care. When pharmacists provide this type
of care, they are using all their knowledge and skills to benefit the
patient. Pharmacists have more to offer patients than safe delivery of
drug products—they have the ability and opportunity to help improve
not only the patient’s health but also the patient’s quality of life. It goes
beyond the traditional, product-oriented role of the pharmacist to the
contemporary role of the pharmacist providing medication manage-
ment services.
■ Patients can comply with drug therapy and other aspects provides. On the other hand, objective data, such as vital
of their care plan. signs and laboratory tests, are observable; can be measured;
■ Patients have all drug therapies necessary to resolve any and are not influenced by memory, emotion, or prejudice.
untreated indications. The nature of the medication history can be confusing
and a topic of debate. Many pharmacists consider it to be
subjective because it is information typically provided by the
PATIENT CARE PROCESS patient. Others believe that because it can be confirmed with
the computerized medication profile from the pharmacy, the
The best way to think about pharmaceutical care within medication history is objective. Although typically considered
pharmacy practice is in terms of the work and interactions objective, the same can be said of laboratory results or vital
that occur between the patient and pharmacist. To fulfill the signs—they can be supplied by the patient or obtained from
pharmaceutical care responsibilities and attain the goals of the lab, patient’s chart, or measured directly. Strictly speaking,
therapy (i.e., appropriate, effective, safe, convenient, and patient-provided data are subjective unless the pharmacist can
economical drug therapy), the pharmacist must use a con- measure it directly (e.g., blood pressure) or verify the informa-
sistent, systematic, and comprehensive process: the patient tion with the lab, patient’s chart, or computerized medication
care process. Figure 1.1 illustrates the steps of the patient care profile/refill record. A common situation that occurs is using
process. It starts with initiating a relationship with the pa- the computerized dispensing record as the medication history.
tient. This relationship can begin with the patient bringing a By doing this, it may not include over-the-counter medications,
new prescription to the pharmacy, requesting a refill prescrip- physician samples, etc. It is best if the pharmacist obtains a
tion, asking a question about a nonprescription product, or thorough history from the patient and then verifies as much as
asking about symptoms he or she is experiencing. During the possible with the computerized medication record. Chapter 3
next step, the pharmacist gathers all the pertinent information provides a detailed description of interviewing techniques and
to evaluate the patient’s health problems and drug therapy ap- components of the health and medication history.
propriately. The specific actions involved with this step will Ways in which subjective and objective data can be
vary according to the patient’s health problems, drug therapy, obtained include talking with the patient as well as with his
and any corresponding drug therapy problems. The informa- or her caregiver, physician, or other healthcare professional;
tion that is obtained may be both subjective and objective. reviewing the prescription, drug therapy profile, or other
Subjective information, such as patient symptoms or chief pharmacy records; reviewing the patient’s medical record, if
complaint, general health and activity level, history of present available; and obtaining physical assessment data (e.g., mea-
illness, past medical history, and social history, is obtained di- suring vital signs).
rectly from the patient and/or caregiver and typically cannot
be directly measured. Because subjective data cannot be mea-
sured or observed, pharmacists are limited in their ability to
Patient Assessment
verify the accuracy of these data that the patient or caregiver A key component of the patient care process just described
is assessment of the patient’s health and drug-related infor-
mation. For pharmacists to successfully incorporate pharma-
ceutical care (i.e., patient-centered care) into their practice,
Initiate relationship with the patient or caregiver. they must have knowledge and skills in patient assessment.
Once all the pertinent subjective and objective information
has been obtained, the pharmacist assesses that informa-
tion and looks for drug therapy problems (see Table 1.1).
Gather patient information Patient assessment is defined as the process through which
(subjective and objective). the pharmacist evaluates patient information (both subjective
and objective) that was gathered from the patient and other
sources (e.g., drug therapy profile, medical record, etc.) and
makes decisions regarding (1) the health status of the patient,
Assess information (2) drug therapy needs and problems, (3) interventions that
(patient assessment). will resolve identified drug problems and prevent future prob-
lems, and (4) follow-up to ensure that patient outcomes are
being met. The primary purpose of patient assessment is to
identify, resolve, and prevent drug therapy problems. Because
Develop patient care plan. the responsibilities of pharmaceutical care and patient assess-
ment are so intertwined, a pharmacist cannot adequately pro-
vide pharmaceutical care without assessing patients.
As with collecting patient data, it is best to use a systematic,
Implement care plan/intervention. consistent process for patient data evaluation and assessment.
This framework for organizing and evaluating patient-specific
data is termed the pharmacotherapy workup and should be
used each time the pharmacist makes a drug therapy decision.
Follow-up. Figure 1.2 illustrates the components involved with the phar-
macotherapy workup. During the pharmacotherapy workup,
FIG U R E 1 . 1 Patient care process. the pharmacist systematically and repeatedly questions and
INDICATION Signs and symptoms ■ What are the other possible causes of the patient’s
complaints/symptoms or abnormal objective/physical
findings?
Lab values ■ Consider other medical conditions.
■ Are each of the medications appropriately indicated?
■ Appropriate medical condition for each drug?
■ Are each of the medications the most efficacious and
EFFECTIVENESS Goals of therapy/ the safest possible?
patient outcomes ■ For the medical condition?
■ For the patient? (Consider age, gender, renal and
liver function, other medical conditions, and adverse
Adverse effects.)
SAFETY ■ Is the dose the most effective and the safest possible?
effects/toxicity
■ Correct dose? (Consider age, renal and liver func-
tion, weight, and other medical conditions.)
■ Is the patient experiencing any adverse effects from
COMPLIANCE Patient behavior the drug therapy?
■ If yes, can any of the adverse effects be resolved?
■ Are there any drug interactions that will impair efficacy
or safety?
Signs and symptoms ■ Consider prescription and nonprescription drugs.
UNTREATED ■ Are there any drug–food or drug–laboratory test
INDICATIONS interactions?
Lab values ■ Is the patient able to follow the drug regimen?
■ Does the patient understand how to appropriately
FIGUR E 1 . 2 Pharmacotherapy workup. (Based on information take the medications?
in Cipolle RJ, Strand LM, Morley PC. The assessment. In: Cipolle ■ Can the patient afford the drug therapy?
RJ, Strand L, Morley P, eds. Pharmaceutical Care Practice: The ■ Does the patient need additional drug therapy for an
Patient-Centered Approach to Medication Management, 3rd ed. untreated indication? Synergism with current therapy?
New York: McGraw-Hill, 2012:183–235.) Prophylaxis?
all patient outcomes are met and not to miss any drug-related plan has been implemented, the patient care process recycles
problems, pharmacists need to obtain and evaluate patient once again. The pharmacist may need to gather more data,
signs and symptoms, laboratory values, physical exam data, assess the patient’s progress, and adjust the plan accordingly.
patient compliance, and goals of therapy. These components
are integral to a thorough assessment of the patient and identi-
DOCUMENTATION
fication, resolution, and prevention of drug-related problems.
Many times, pharmacists do not have access to patient data Documenting a patient care encounter is a critical and essen-
such as lab values or physical exam information (e.g., blood tial step in the pharmaceutical care process. It is commonly
pressure readings, blood glucose values). To compensate for understood among pharmacy practitioners that “if you didn’t
this missing information, pharmacists are beginning to learn document it, you didn’t do it.” Documentation is a valuable
and use pertinent physical assessment skills in their practice. communication tool for future encounters with that patient
Examples of physical assessment techniques that are being and with other healthcare professionals. Other reasons why
applied within pharmacy practice include inspection of skin documentation is so critical to the patient-centered care process
abnormalities, blood pressure and heart rate measurement, are listed in Box 1.2. Currently, several different methods are
peak flow readings, bone density testing, blood glucose levels, used to document patient care and PCPs, and various computer
and cholesterol values. Whether physical assessment is per- software options are available to assist the pharmacist with this
formed by a pharmacist or another healthcare professional, process. Good documentation is more than just filling out a
at a minimum, pharmacists must have an understanding of form, however; it should facilitate good patient care. Charac-
the physical assessment process and the corresponding data teristics of useful documentation of patient encounters include:
obtained if they are to provide adequate pharmaceutical care
■ Information that is neat, organized, and able to be found
to patients. The intent of this book is to enhance understand-
quickly
ing of basic physical examination techniques and data as they
apply to patient-centered care—not necessarily for pharma- ■ Information that is easily understandable, so that any health-
cists to become proficient in each of these techniques and care professional can determine what the problems were,
“diagnose” the patient. what actions were taken, and what follow-up is needed
Once all drug-related problems have been identified, it is ■ Accurate subjective and objective information
then necessary to determine the cause for each. Knowing the ■ An assessment of the patient information, focusing on drug
cause of each drug-related problem leads to the most effective therapy problems
solution for the patient. The identified drug therapy problems
are then categorized and prioritized, along with correspond-
■ A plan to resolve any problems that were identified
ing goals and goal criteria (i.e., patient outcomes), and they ■ A therapeutic monitoring plan for future follow-up to
are documented in the patient care plan (PCP) or pharmacy ensure that any problems are resolved and that patient out-
note. Integral to the PCP are the solutions to these problems, comes are met
which are commonly known as interventions. Interventions
are primarily the actions needed to resolve identified drug
therapy problems or to prevent potential problems in the fu-
SOAP Note
ture. These may include (but are not limited to) educating and The most common—and universally recognized—format for
counseling the patient about drug therapy or health-related documenting patient information in the healthcare system is
issues, contacting another healthcare professional to obtain the SOAP note, which is an acronym that stands for Subjective,
more patient information or to make recommendations about Objective, Assessment, and Plan. Each term reflects a section
drug therapy, recommending new or alternate (drug and non- of the note that contains a specific type of information. Using a
drug) therapy, and referring the patient to another healthcare systematic and consistent format, such as the SOAP note, makes
professional. Secondary interventions ensure that the patient the documentation of patient care encounters more efficient.
achieves the goals of therapy. The particular type of interven- The SOAP note is the format that we will be using through-
tion varies according to the patient’s needs, goals of therapy, out the book to document cases in a PCP. The subjective and
and the drug therapy problems that are identified. objective sections contain information from the patient and/or
Another part of the PCP is the follow-up evaluation, com-
monly termed the monitoring plan, which outlines factors
that will determine attainment of the desired patient outcomes
(e.g., blood pressure measurement, laboratory data, or talking 1.2 Value of Documentation
with the patient). In selecting the most appropriate interven- ■ Provides a permanent record of patient information
tion and monitoring plan, the pharmacist should also actively ■ Provides a permanent record and evidence of pharma-
consider the patient’s needs and desires and incorporate these ceutical care activities by the pharmacist
into development of the plan. Ideally, the patient should be ■ Communicates essential information to other pharma-
involved throughout the entire pharmaceutical care process. cists and healthcare professionals
The final step of the PCP, which is frequently overlooked ■ Serves as a legal record of patient care that was
or eliminated due to time constraints, is implementing the provided
monitoring plan and follow-up to determine the outcomes of ■ Provides evidence of patient interventions and medica-
drug therapy. For example, the pharmacist may contact the pa- tion therapy management services for reimbursement
tient to evaluate drug therapy compliance or drug side effects. Based on information in Currie JD. Documentation. In: Rovers JP, Currie
Other follow-up actions may include measuring vital signs or JD, Hagel HP, et al, eds. A Practical Guide to Pharmaceutical Care, 3rd ed.
checking other physical or laboratory data. Note that after the Washington, DC: American Pharmaceutical Association, 2007:139–160.
caregiver, physical exams, as well as laboratory and diagnostic to ensure that problems are actually corrected, future prob-
tests. Drug therapy problems are identified from the subjective lems do not develop, and drug therapy goals are met. The
and objective information and are documented in the assess- follow-up should include monitoring parameters that need to
ment section. The plan describes needed actions to resolve the be assessed as well as the interval for the next assessments
drug therapy problems identified and monitoring/follow-up for (e.g., “Check blood pressure—2 weeks.”). It is also helpful
evaluation of drug therapy outcomes. to include guidelines concerning what should be done with
The subjective section includes information that is given by the data at the time of the follow-up (e.g., “Check blood
the patient, family members, significant others, or caregivers. pressure in 2 weeks. If ⬍140/90 mm Hg and no side effects,
The type of information in this section includes: continue current medications. If 140 to 160/90 to 100 mm
Hg, recheck blood pressure in 2 weeks. If ⬎160/100 mm Hg,
■ Complaints/symptoms or reason for the visit from the increase lisinopril to 40 mg QD. If having side effects [cough,
patient in his or her own words (chief complaint) light-headedness, dizziness], may need to change to doxazo-
■ Recent history that pertains to those symptoms (history of sin, 2 mg QHS.”). This information expedites the follow-up
present illness) process, especially if a different pharmacist sees the patient at
this time. A general rule of thumb is that a colleague should
■ Past medical history
be able to read, interpret, and act on the plan if the pharma-
■ Medication history, including compliance and adverse effects cist who documented the note is not available.
(from the patient, not the computerized medication profile)
■ Allergies
■ Social and/or family history
Problem-Oriented Note
■ Review of systems In the problem-oriented note, a patient’s active problems are
listed and a SOAP note is written for each problem or closely
The objective section includes data that are obtained from related group of problems. The problems may be regarding
the patient and that can be measured objectively. Common the patient’s disease states or may be drug therapy problems.
information in this section includes: If the patient assessment does not reveal any drug therapy
problems, then the note should be so titled (e.g., “No drug
■ Vital signs therapy problems identified.”), and sufficient data that led to
■ Physical findings or physical examination (if possible) this conclusion should be included in the SOAP note. Because
both the SOAP note (with all the problems documented
■ Laboratory test results (from the lab if available, not from
in one note) and the problem-oriented note are commonly
the patient)
used, either format is acceptable. The same format, however,
■ Serum drug concentrations (if available) should be used consistently from pharmacist to pharmacist
■ Various diagnostic test results (if available) at a particular practice site. Throughout this book, the SOAP
■ Computerized medication profile with refill information note format is used to document the PCP or pharmacy note
(if available) when illustrating patient case scenarios.
Typical areas of focus for patient assessment activities include Medication management services are designed to optimize
anticoagulation, diabetes, hypertension, and lipid clinics. patient outcomes through improved medication use, reduce
Ambulatory clinics are the most common setting in which the risk of adverse events and drug interactions, and increase
pharmacists perform physical examination activities with pa- patient compliance for targeted beneficiaries. These beneficia-
tients (e.g., blood pressure measurement). ries include those with multiple chronic disease states such as
Because community pharmacies are typically associated diabetes, hypertension and hyperlipidemia, multiple medica-
with the drug product rather than with patient care, they are tions covered under Part D, and outpatient medication costs
sometimes overlooked as a setting for pharmaceutical care or that exceed an amount to be determined by the U.S. Depart-
patient assessment activities; however, the converse is actually ment of Health and Human Services (DHHS).
true. The community pharmacy provides abundant oppor- Medication management services may encompass a broad
tunities for patient assessment on a daily basis. Community array of consultation activities and are very similar to the pa-
pharmacists are the most accessible healthcare professional tient-centered care activities described earlier. At a minimum,
and are routinely trusted by society. In addition, the self-care medication management requires the pharmacist to review all
revolution is influencing the number of individuals who are medications the patient is taking, identify adverse drug effects
using nonprescription products. Self-care is anything that a and drug interactions, and determine patient compliance with
patient does on his or her own to identify, treat, or prevent the prescribed medication regimen. A more comprehensive
illness/disease or increase his or her sense of wellness without approach includes the steps listed in Table 1.2.
consulting a healthcare professional. The self-care movement MTM consultation would also include evaluation of any
is being partly fueled by an increasing number of prescription drug-related problems which will improve the patient’s health-
drugs being reclassified as nonprescription drugs, escalating care outcomes and/or reduce drug costs as described in detail
elderly population (age ⬎65 years), inflated healthcare costs,
and a high percentage of underinsured or uninsured people in
the United States. Other influential factors include healthcare TABLE
TABL
TA B E 1.2
BL 1. 2 GGuidelines
uide
ui de
eline
es for
fo
or Comprehensive
Comp
Com
Co mpre
ehe
ens
nsiv
ivee
information being readily available on the Internet, patients
Medication
M
Meedi
d ca
cati
tion
ti
ion MManagement
an
a nag
geem
me en
nt
becoming more educated and empowered about healthcare
and treatment options, as well as patients preferring the con- An assessment of the patient’s medication-related needs
venience and decreased cost associated with self-treatment ■ All medications are reviewed and documented with
versus the time and expense required to visit a medical pro- the patient.
vider. Pharmacists are the most logical healthcare provider to ■ The medication experience of the patient is discussed
assist and guide patients in making wise choices about non- and recorded.
prescription products, dietary products, and/or homeopathic ■ The patient’s medication history including allergies/
medications as well as when to consult a physician. reactions is taken.
■ All current medications and their doses (the way they
are actually being taken by the patient) are reviewed
MEDICATION THERAPY MANAGEMENT with the patient and documented.
SERVICES ■ Each medication is assessed for the medical condition
or indication for which it is taken.
Another ideal patient care opportunity for pharmacists is the ■ The clinical status of the patient is assessed/deter-
provision of medication management services (also known mined for each drug/condition treated/prevented.
as medication therapy management [MTM]), which are the ■ The clinical goals of therapy for each medication are
identifiable practice activities surrounding the professional re- ascertained and documented.
sponsibility of managing a patient’s medications (i.e., a com-
Identification of the patient’s medication-related problems
prehensive assessment of the patient’s drug-related needs, an
individualized care plan to determine desired goals of therapy
■ Indication/appropriateness of the medication
with the patient, and appropriate follow-up to evaluate pa-
■ Effectiveness of the medication
tient outcomes that result from the care plan). These activities
■ Safety of the medication
are needed to meet the standard of care, which ensures each
■ Compliance/adherence to the medication
patient’s medications are individually assessed to determine Develop a patient care plan with individualized therapy
that each medication is appropriate for the medical condi- goals and personalized interventions.
tion being treated, that the medication is being effective and ■ The patient’s medication care plan is developed by the
achieving the goals established, that the medication is safe for pharmacist directly with the patient and in collabora-
the patient in the presence of comorbidities and other medica- tion with the primary care team/healthcare providers.
tions the patient may be taking, and the patient is able and Follow-up evaluation to determine actual patient outcomes
willing to take the medication as intended.
■ Follow-up evaluations allow the pharmacist in collabo-
Medication management services are relatively new. The
ration with the primary care medical team to determine
term and surrounding activities became more pronounced in
the actual outcomes resulting from the recommended
2006 when the U.S. Federal Government implemented a new
interventions.
Medicare drug benefit (Part D), in which the elderly popula-
tion receives coverage for outpatient prescription medications. Adapted from PCPCC Resource Guide: Appendix A: Guidelines for the
As part of the new Medicare Part D benefit, a new service was practice and documentation of comprehensive medication management in
the patient-centered medical home. https://www.pcpcc.org/sites
needed to help patients manage these covered medications, /default/files/resources/Appendix_A_Guidelines_for_the_Practice_and
which evolved into the term medication therapy management. _Documentation.pdf. Accessed December 16, 2014.
CASE STUDY
JB is a 74-year-old man who comes to the pharmacy for probably causing the light-headedness and decreased
a refill of his antihypertensive medication, lisinopril. As he energy. I’ll go ahead and get the refill for you, but
approaches the pharmacy counter, he loses his balance make sure that you take it just once a day.
slightly, but he catches himself on the counter. The phar-
JOE: Okay. I guess I never paid any attention to it. I just
macist asks, “Are you okay, Joe?” The patient answers,
figured it was the same as the other medicine I’m taking.
“Oh, yes, I’m fine. I just stumbled a little. I do that quite
From now on, I’ll take it with my breakfast every morning.
often these days. I need a refill of my blood pressure med-
icine.” The pharmacist pulls up Joe’s drug therapy profile PHARMACIST: That would be fine. I also want you to
on the computer screen and asks, “What’s the name of the come back in a week so that I can recheck your blood
medication?” The patient answers, “I need my lisinopril.” pressure and heart rate and see if you’re feeling better.
ASSESSMENT OF THE PATIENT JOE: That sounds like a good idea to me. Thanks for
taking the time to check into this.
PHARMACIST: So how long have you been having
problems with your balance?
PATIENT CARE PLAN
JOE: Oh, it’s not a problem. I’ve just been a little light-
headed the past couple of weeks. I guess it’s just old age. Patient Name: JB
PHARMACIST: How is your energy level? Medical Problems:
Hypertension
JOE: I don’t do a whole lot anymore, so I guess I don’t Current Medications:
need much energy at my age. Lisinopril 25 mg, one tablet once daily
PHARMACIST: How have you been feeling otherwise? S: Comes in for lisinopril refill. C/O occasional light-
Have you been having any other problems? headedness, decreased energy level, and loss of
JOE: No, otherwise I feel okay.
balance over the past 2 weeks. No other C/O.
Currently taking the lisinopril twice a day for the
PHARMACIST: I notice in your profile that you just started past 2 weeks.
taking the lisinopril 2 weeks ago. How have you been
O: Saw patient lose his balance on way to the phar-
taking it?
macy counter
JOE: I take it with breakfast and supper. Just like my
Heart rate: 78 bpm
other blood pressure medicine.
Blood pressure: 104/72, 102/70 mm Hg
PHARMACIST: Actually, you should be taking it just once A: Hypotension—new onset—probably due to non-
a day. Why don’t you have a seat over here and let me adherence with the lisinopril
check your blood pressure and heart rate. They could
be too low from the lisinopril, and that could be causing P: 1. Instructed patient to take the lisinopril once a
your light-headedness and low energy. day with breakfast rather than twice a day as
Joe’s heart rate is 78 bpm, and his blood pressure is he has been doing
104/72 and 102/70 mm Hg. 2. Follow up in 1 week to recheck heart rate and
PHARMACIST: Your blood pressure is slightly lower blood pressure. If still low, call the physician
than it should be. I think this may be due to taking the and see about possibly D/Cing the lisinopril
lisinopril twice a day rather than once a day, and this is Pharmacist: Rachel Smith, Pharm.D.
earlier in the chapter. If any drug therapy problems are identi- Self-Assessment Questions
fied, the pharmacist intervenes to correct or resolve the problem
and establishes a follow-up monitoring plan. Interventions may 1. Briefly describe the concept of pharmaceutical care.
include working with the patient/caregiver or collaborating with 2. What are the pharmacist’s primary responsibilities in
the prescriber to address specific medication problems. MTM providing pharmaceutical care to patients?
consultations also provide opportunities for pharmacists to edu- 3. Briefly describe how the concept of patient assessment
cate and counsel patients about appropriate medication use and is intertwined with pharmaceutical care.
strategies to enhance medication regimen adherence. In addition,
the pharmacist needs to document patient interactions not only
for good patient care but also for reimbursement of services. Critical Thinking Question
1. In the patient case example discussed in this chapter,
Example the patient’s hypotension was probably caused by non-
The case from the beginning of the chapter is reproduced and compliance with the lisinopril. As a pharmacist who
continued in the “Case Study” section. provides pharmaceutical care, what would you do if the
patient comes back to the pharmacy a week later, has Cipolle RJ, Strand LM, Morley PC. The assessment. In: Cipolle
been taking the lisinopril correctly (i.e., once daily), but RJ, Strand L, Morley P, eds. Pharmaceutical Care Practice:
The Patient-Centered Approach to Medication Management, 3rd
still has a low blood pressure?
ed. New York: McGraw-Hill, 2012:183–235.
Currie JD. Documentation. In: Rovers JP, Currie JD, Hagel HP, et al,
BIBLIOGRAPHY eds. A Practical Guide to Pharmaceutical Care, 3rd ed. Washing-
ton, DC: American Pharmaceutical Association, 2007:139–160.
American Pharmaceutical Association. APhA Principles of Practice Currie JD. The case for pharmaceutical care. In: Rovers JP, Currie JD,
for Pharmaceutical Care. Washington, DC: American Pharmaceu- Hagel HP, et al, eds. A Practical Guide to Pharmaceutical Care,
tical Association, 1995. http://www.pharmacist.com/principles 3rd ed. Washington, DC: American Pharmaceutical Association,
-practice-pharmaceutical-care. Accessed December 16, 2014. 2007:3–21.
American Pharmacists Association. Medication Therapy Manage- Currie JD, Doucette WR, Kuhle J, et al. Identification of essential
ment in Community Pharmacy Practice: Core Elements of an elements in the documentation of pharmacist-provided care. J Am
MTM Service Model. Washington, DC: American Pharmacists Pharm Assoc 2003;43:41–49.
Association, 2005. De Oliveira DR, Shoemaker SJ. Achieving patient centeredness in
American Pharmacists Association. Understanding Medicare Reform: pharmacy practice. J Am Pharm Assoc 2006;46(1):56–66.
What Pharmacists Need to Know Monograph 2: Medication Doucette WR, McDonough RP, Klepser D, et al. Comprehensive
Therapy Management Services and Chronic Care Improvement medication therapy management: identifying and resolving drug-
Programs. Washington, DC: American Pharmacists Association, related issues in a community pharmacy. Clin Ther 2005;27(7):
2004. 1104–1111.
American Pharmacists Association. What is medication therapy man- Grainger-Rousseau TJ, Miralles MA, Hepler CD, et al. Therapeutic
agement? http://www.pharmacist.com/mtm. Accessed December 16, outcomes monitoring: applications of pharmaceutical care guide-
2014. lines to community pharmacy. J Am Pharm Assoc 1997;NS37:
American Pharmacists Association, National Association of Chain 647–661.
Drug Stores Foundation. Medication Therapy Management in Phar- Henderson ML. Self-care and nonprescription pharmacotherapy.
macy Practice: Core Elements of an MTM Service. Washington, DC: In: Krinsky DL, Berardi RR, Ferreri SF, et al, eds. Handbook of
American Pharmacists Association, 2008. Nonprescription Drugs: An Interactive Approach to Self-Care,
American Society of Health-System Pharmacists. ASHP guidelines on 17th ed. Washington, DC: American Pharmacists Association,
a standardized method for pharmaceutical care. Am J Health-Syst 2012:3–14.
Pharm 1996;53:1713–1716. Hepler CD, Strand LM. Opportunities and responsibilities in phar-
American Society of Health-System Pharmacists. ASHP statement on maceutical care. Am J Hosp Pharm 1990;47:533–543.
pharmaceutical care. Am J Hosp Pharm 1993;50:1720–1723. Joint Commission of Pharmacy Practitioners. Pharmacists’ patient
Brown LM, Isetts BJ. Patient assessment and consultation. In: Krinsky care process. https://www.pharmacist.com/sites/default/files/
DL, Berardi RR, Ferreri SF, et al, eds. Handbook of Nonprescrip- patientcareprocess.pdf. Accessed March 30, 2015.
tion Drugs: An Interactive Approach to Self-Care, 17th ed. Wash- Kane MP, Briceland LL, Hamilton RA. Solving drug-related prob-
ington, DC: American Pharmacists Association, 2012:17–36. lems. US Pharm 1995;20:55–74.
Cipolle RJ, Strand LM, Morley PC. Drug therapy problems. In: Rovers JP. Identifying drug therapy problems. In: Rovers JP, Currie
Cipolle RJ, Strand L, Morley P, eds. Pharmaceutical Care Prac- JD, Hagel HP, et al, eds. A Practical Guide to Pharmaceutical
tice: The Patient-Centered Approach to Medication Management, Care, 3rd ed. Washington, DC: American Pharmacists Associa-
3rd ed. New York: McGraw-Hill, 2012:141–181. tion, 2007:23–46.
Cipolle RJ, Strand LM, Morley PC. Medication management ser- Rovers JP. Patient data collection. In: Rovers JP, Currie JD, Hagel
vices. In: Cipolle RJ, Strand L, Morley P, eds. Pharmaceutical HP, et al, eds. A Practical Guide to Pharmaceutical Care, 3rd ed.
Care Practice: The Patient-Centered Approach to Medication Washington, DC: American Pharmacists Association, 2007:47–88.
Management, 3rd ed. New York: McGraw-Hill, 2012:1–33. Rovers JP. Patient data evaluation. In: Rovers JP, Currie JD, Hagel HP,
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care as the pro- et al, eds. A Practical Guide to Pharmaceutical Care, 3rd ed. Wash-
fessional practice for patient-centered medication management ington, DC: American Pharmaceutical Association, 2007:89–106.
services. In: Cipolle RJ, Strand L, Morley P, eds. Pharmaceuti- Tomechko MA, Strand LM, Morley PC, et al. Q and A from
cal Care Practice: The Patient-Centered Approach to Medication the pharmaceutical care project in Minnesota. Am Pharm
Management, 3rd ed. New York: McGraw-Hill, 2012:37–71. 1995;NS35(4):30–39.
GLOSSARY TERMS
◗ Cultural pluralism For centuries, millions of people representing hundreds of different
◗ Culture cultures and nationalities have left their countries of birth to make
◗ Ethnicity the United States their home. Until recently, many of these immigrants
willingly surrendered their individual cultural identity and adopted
◗ Ethnocentrism
the European American culture and the English language as their own,
◗ Prejudice thereby leading to the familiar characterization of the United States as
◗ Race a “melting pot.” Today, however, sequestration rather than assimila-
◗ Stereotype tion may be more accurate when describing the prevalent behavior of
various ethnic groups. Recent immigrants now often confine them-
◗ Subculture
selves to their own cultural enclaves and interact mainly within their
own cultural groups. By 2050, the United States will be a “majority
minority” nation, with more than half the population coming from
racial or ethnic minority backgrounds. In light of these changes, the
term cultural pluralism has been coined. Cultural pluralism (or multi-
culturalism) refers to the United States as having tremendous cultural
diversity rather than one dominant “American” culture. This diversity
requires us, as pharmacists, to become aware of our own culturally
determined preferences, values, and behaviors and to appreciate those
of other cultures. It also challenges us to examine the issues and prob-
lems associated with cultural diversity in our daily practice.
Because cultural belief systems have a significant impact on an in-
dividual’s health-related behaviors, pharmacists must demonstrate a
genuine respect for cultural differences while at the same time pro-
viding effective patient-centered care. As described in Chapter 1, the
pharmacist’s role is to identify, resolve, and prevent medication-related
problems, which enhance positive patient outcomes. This specifically
involves interviewing patients, taking health and medication histories,
obtaining physical assessment data, monitoring and evaluating pa-
tient information (both subjective and objective), evaluating patient
compliance, and educating as well as counseling patients. In addition,
pharmacists frequently interact with colleagues and other healthcare
professionals who represent different sociocultural segments of society.
Considering these various aspects, the provision of patient-centered
care requires a pharmacist to possess effective cross-cultural skills
when dealing with patients, colleagues, and other healthcare profes-
sionals. Cross-cultural competency is essential for providing quality
care in today’s healthcare environment.
WHAT IS CULTURE?
Culture is a simple word with complex meanings that encompass the
entire domain of human activities. Specifically, culture is the integrated
pattern of thoughts, communications, actions, customs, beliefs, values,
and institutions associated, wholly or partially, with racial, ethnic, or
11
linguistic groups as well as religious, spiritual, biological, geo- and illness that may differ from their own. A major portion of
graphical, or sociological characteristics. Culture is dynamic patient-centered care relies on communication with patients
in nature, and individuals may identify with multiple cultures and other healthcare professionals, so pharmacists must also
over the course of their lifetimes. Culture reflects the whole recognize and accept variations in communication skills and
of human behavior, including values, attitudes, and ways of behaviors that result from differing cultural backgrounds.
relating to and communicating with each other. It also en- Ethnocentrism is the belief in the superiority of one’s own
compasses an individual’s concepts of self, universe, time, and group or culture while also expressing disdain and contempt
space as well as health, disease, and illness. Because we all for other groups and cultures. A European American pharma-
have varied aspects to our life, individuals typically belong cist working in a clinic in a Mexican American border town
to more than one cultural group or subculture, which refers would be displaying ethnocentrism if he or she arbitrarily dis-
to separate groups within a larger cultural context. These missed a patient’s herbal remedy as being ineffective.
multiple cultural groups can result from a person’s religion, Prejudice is the preconceived judgment or opinion of an-
occupation, gender, age, illness, and many other factors. For other person based on direct or indirect experiences. An Anglo
example, an Irish, Catholic, female patient with cancer will American pharmacist working in a clinic in an inner city envi-
reflect various aspects, in some degree, of all these cultural ronment who recommends oral contraceptives to all African
groups. The term culture should not be confused with the American females based on the belief that these women have
term race, however. Race refers to groupings of people with children indiscriminately would be displaying prejudice.
the same biological and familial heredity. A person’s race typi- Stereotypes are fixed perceptions or images of a group
cally is reflected in physical characteristics, such as skin color, that reject the existence of individuality within that group.
and is continued through generations. Lipson defines ethnicity This can occur even with the best of intentions. Table 2.1
as “a socially, culturally, and politically constructed group of outlines generalizations that may apply to various ethnic
individuals that holds a common set of characteristics not groups; however, when this type of cultural information is
shared by others with whom its members come in contact.” applied indiscriminately, without considering the uniqueness
of the individual, stereotyping can occur. Stereotyping is an
even greater risk when pharmacists do not recognize their
Characteristics of Culture own values and beliefs. A pharmacist who displays ethno-
centrism or prejudice, or who stereotypes individuals, will
Culture has four primary characteristics: (1) It is learned from
gather data selectively and in accordance with his or her own
birth through group socialization and language acquisition;
personal values and judgments. These biases can limit—or
(2) it is adapted to specific conditions (i.e., environmental
even prevent—important patient information from being ob-
and technical factors); (3) it is dynamic and ever-changing;
tained and, in turn, distort the corresponding assessment of
and (4) it is shared by most, if not all, members of that par-
the patient and his or her drug therapy problems.
ticular cultural group. Common features of culture include
To apply general cultural information, pharmacists must
patterns of interaction and communication, social organi-
seek further information to determine whether the cultural
zations, role expectation, politics, geography, and econom-
generalizations fit the individual. Thus, as you begin to work
ics. A person’s culture is expressed through shared norms
with various patients, be aware of and sensitive to core cultural
(i.e., cultural boundaries), meanings, and values. In addition,
issues. Once identified, the pharmacist can explore the issues by
culture helps people to learn and to define their relationship
inquiring about the patient’s own belief or preference. Box 2.1
with immediate groups and with members of society in gen-
identifies ways to develop cultural sensitivity. The first step is
eral. Our culture influences the way that we think as well as
to examine your own culturally based values, beliefs, attitudes,
how we interact and conduct our activities of daily living.
and practices—especially concerning health and illness. Also,
Culture is shaped by a person’s nationality, socioeconomic
keep in mind that pharmacists have been socialized into a dis-
and professional groupings, special needs, and lifestyle prefer-
tinct professional culture and that this culture (like others) in-
ences. Our attitudes, beliefs, and customs are determined by
stills its own beliefs and norms regarding health and illness. For
our cultural heritage, which defines our identity. Sometimes,
the majority of pharmacists, this professional culture includes
our culture provides us with unlimited opportunities and per-
an acceptance of the biomedical theory of health and illness.
sonal freedom to exercise our own free will. At other times,
(This theory and its alternatives are discussed in more depth
it imposes enormous restrictions by preventing us from step-
in the following section.) In addition, each pharmacist has a
ping outside cultural boundaries (i.e., norms).
culture that is defined by his or her own personal situation.
When a pharmacist interacts with someone from a cul-
Ethnocentrism, Prejudice, and Stereotypes ture with differing beliefs, conflict can result. Because of this
potential conflict, it is helpful to explore your own percep-
Culture also influences how people view and judge those who tion, beliefs, and understanding of health and illness that
seem to be different. Core cultural issues are situations, inter- have developed from your cultural background. Sometimes,
actions, and behaviors that have potential for cross-cultural this requires significant introspection. The goal of this reflec-
misunderstanding. These core cultural issues often revolve tion is to develop cultural competence. Cultural and linguis-
around issues such as authority, physical contact, communi- tic competence, as defined by the Office of Minority Health,
cation styles, gender, sexuality, spirituality, and family. Phar- is a set of congruent behaviors, attitudes, and policies that
macists reflect society’s cultural mix as well as represent their come together in a system, agency, or among professionals
own cultural group as a healthcare profession. To provide that enables effective work in cross-cultural situations. To
patient-centered care appropriately, pharmacists must accept assist with your cultural self-assessment, answer the ques-
a wide variety of beliefs, practices, and ideas about health tions in Box 2.2. After answering these questions, reflect on
(continued)
(continued)
professional situations in which you have encountered beliefs assessment are discussed. When working with patients, cultural
that differ from your own. Did you accept these differences, differences will undoubtedly exist. You must be sensitive to these
or did you discount them in favor of your own? Develop a differences and be certain that you understand exactly what the
plan for how you will react in the future. patient means—and what the patient thinks you mean. This is
an underlying necessity during all patient assessments, no matter
Adapted from Stulc P. The family as bearer of culture. In: Cookfair JN, ed. Nursing Adapted from Spector R. Cultural Diversity in Health and Illness. Norwalk:
Process and Practice in the Community. St. Louis: Mosby–Year Book, 1990. Prentice Hall, 2003.
I see increasing reason to believe that the view formed some time
back as to the origin of the Makonde bush is the correct one. I have
no doubt that it is not a natural product, but the result of human
occupation. Those parts of the high country where man—as a very
slight amount of practice enables the eye to perceive at once—has not
yet penetrated with axe and hoe, are still occupied by a splendid
timber forest quite able to sustain a comparison with our mixed
forests in Germany. But wherever man has once built his hut or tilled
his field, this horrible bush springs up. Every phase of this process
may be seen in the course of a couple of hours’ walk along the main
road. From the bush to right or left, one hears the sound of the axe—
not from one spot only, but from several directions at once. A few
steps further on, we can see what is taking place. The brush has been
cut down and piled up in heaps to the height of a yard or more,
between which the trunks of the large trees stand up like the last
pillars of a magnificent ruined building. These, too, present a
melancholy spectacle: the destructive Makonde have ringed them—
cut a broad strip of bark all round to ensure their dying off—and also
piled up pyramids of brush round them. Father and son, mother and
son-in-law, are chopping away perseveringly in the background—too
busy, almost, to look round at the white stranger, who usually excites
so much interest. If you pass by the same place a week later, the piles
of brushwood have disappeared and a thick layer of ashes has taken
the place of the green forest. The large trees stretch their
smouldering trunks and branches in dumb accusation to heaven—if
they have not already fallen and been more or less reduced to ashes,
perhaps only showing as a white stripe on the dark ground.
This work of destruction is carried out by the Makonde alike on the
virgin forest and on the bush which has sprung up on sites already
cultivated and deserted. In the second case they are saved the trouble
of burning the large trees, these being entirely absent in the
secondary bush.
After burning this piece of forest ground and loosening it with the
hoe, the native sows his corn and plants his vegetables. All over the
country, he goes in for bed-culture, which requires, and, in fact,
receives, the most careful attention. Weeds are nowhere tolerated in
the south of German East Africa. The crops may fail on the plains,
where droughts are frequent, but never on the plateau with its
abundant rains and heavy dews. Its fortunate inhabitants even have
the satisfaction of seeing the proud Wayao and Wamakua working
for them as labourers, driven by hunger to serve where they were
accustomed to rule.
But the light, sandy soil is soon exhausted, and would yield no
harvest the second year if cultivated twice running. This fact has
been familiar to the native for ages; consequently he provides in
time, and, while his crop is growing, prepares the next plot with axe
and firebrand. Next year he plants this with his various crops and
lets the first piece lie fallow. For a short time it remains waste and
desolate; then nature steps in to repair the destruction wrought by
man; a thousand new growths spring out of the exhausted soil, and
even the old stumps put forth fresh shoots. Next year the new growth
is up to one’s knees, and in a few years more it is that terrible,
impenetrable bush, which maintains its position till the black
occupier of the land has made the round of all the available sites and
come back to his starting point.
The Makonde are, body and soul, so to speak, one with this bush.
According to my Yao informants, indeed, their name means nothing
else but “bush people.” Their own tradition says that they have been
settled up here for a very long time, but to my surprise they laid great
stress on an original immigration. Their old homes were in the
south-east, near Mikindani and the mouth of the Rovuma, whence
their peaceful forefathers were driven by the continual raids of the
Sakalavas from Madagascar and the warlike Shirazis[47] of the coast,
to take refuge on the almost inaccessible plateau. I have studied
African ethnology for twenty years, but the fact that changes of
population in this apparently quiet and peaceable corner of the earth
could have been occasioned by outside enterprises taking place on
the high seas, was completely new to me. It is, no doubt, however,
correct.
The charming tribal legend of the Makonde—besides informing us
of other interesting matters—explains why they have to live in the
thickest of the bush and a long way from the edge of the plateau,
instead of making their permanent homes beside the purling brooks
and springs of the low country.
“The place where the tribe originated is Mahuta, on the southern
side of the plateau towards the Rovuma, where of old time there was
nothing but thick bush. Out of this bush came a man who never
washed himself or shaved his head, and who ate and drank but little.
He went out and made a human figure from the wood of a tree
growing in the open country, which he took home to his abode in the
bush and there set it upright. In the night this image came to life and
was a woman. The man and woman went down together to the
Rovuma to wash themselves. Here the woman gave birth to a still-
born child. They left that place and passed over the high land into the
valley of the Mbemkuru, where the woman had another child, which
was also born dead. Then they returned to the high bush country of
Mahuta, where the third child was born, which lived and grew up. In
course of time, the couple had many more children, and called
themselves Wamatanda. These were the ancestral stock of the
Makonde, also called Wamakonde,[48] i.e., aborigines. Their
forefather, the man from the bush, gave his children the command to
bury their dead upright, in memory of the mother of their race who
was cut out of wood and awoke to life when standing upright. He also
warned them against settling in the valleys and near large streams,
for sickness and death dwelt there. They were to make it a rule to
have their huts at least an hour’s walk from the nearest watering-
place; then their children would thrive and escape illness.”
The explanation of the name Makonde given by my informants is
somewhat different from that contained in the above legend, which I
extract from a little book (small, but packed with information), by
Pater Adams, entitled Lindi und sein Hinterland. Otherwise, my
results agree exactly with the statements of the legend. Washing?
Hapana—there is no such thing. Why should they do so? As it is, the
supply of water scarcely suffices for cooking and drinking; other
people do not wash, so why should the Makonde distinguish himself
by such needless eccentricity? As for shaving the head, the short,
woolly crop scarcely needs it,[49] so the second ancestral precept is
likewise easy enough to follow. Beyond this, however, there is
nothing ridiculous in the ancestor’s advice. I have obtained from
various local artists a fairly large number of figures carved in wood,
ranging from fifteen to twenty-three inches in height, and
representing women belonging to the great group of the Mavia,
Makonde, and Matambwe tribes. The carving is remarkably well
done and renders the female type with great accuracy, especially the
keloid ornamentation, to be described later on. As to the object and
meaning of their works the sculptors either could or (more probably)
would tell me nothing, and I was forced to content myself with the
scanty information vouchsafed by one man, who said that the figures
were merely intended to represent the nembo—the artificial
deformations of pelele, ear-discs, and keloids. The legend recorded
by Pater Adams places these figures in a new light. They must surely
be more than mere dolls; and we may even venture to assume that
they are—though the majority of present-day Makonde are probably
unaware of the fact—representations of the tribal ancestress.
The references in the legend to the descent from Mahuta to the
Rovuma, and to a journey across the highlands into the Mbekuru
valley, undoubtedly indicate the previous history of the tribe, the
travels of the ancestral pair typifying the migrations of their
descendants. The descent to the neighbouring Rovuma valley, with
its extraordinary fertility and great abundance of game, is intelligible
at a glance—but the crossing of the Lukuledi depression, the ascent
to the Rondo Plateau and the descent to the Mbemkuru, also lie
within the bounds of probability, for all these districts have exactly
the same character as the extreme south. Now, however, comes a
point of especial interest for our bacteriological age. The primitive
Makonde did not enjoy their lives in the marshy river-valleys.
Disease raged among them, and many died. It was only after they
had returned to their original home near Mahuta, that the health
conditions of these people improved. We are very apt to think of the
African as a stupid person whose ignorance of nature is only equalled
by his fear of it, and who looks on all mishaps as caused by evil
spirits and malignant natural powers. It is much more correct to
assume in this case that the people very early learnt to distinguish
districts infested with malaria from those where it is absent.
This knowledge is crystallized in the
ancestral warning against settling in the
valleys and near the great waters, the
dwelling-places of disease and death. At the
same time, for security against the hostile
Mavia south of the Rovuma, it was enacted
that every settlement must be not less than a
certain distance from the southern edge of the
plateau. Such in fact is their mode of life at the
present day. It is not such a bad one, and
certainly they are both safer and more
comfortable than the Makua, the recent
intruders from the south, who have made USUAL METHOD OF
good their footing on the western edge of the CLOSING HUT-DOOR
plateau, extending over a fairly wide belt of
country. Neither Makua nor Makonde show in their dwellings
anything of the size and comeliness of the Yao houses in the plain,
especially at Masasi, Chingulungulu and Zuza’s. Jumbe Chauro, a
Makonde hamlet not far from Newala, on the road to Mahuta, is the
most important settlement of the tribe I have yet seen, and has fairly
spacious huts. But how slovenly is their construction compared with
the palatial residences of the elephant-hunters living in the plain.
The roofs are still more untidy than in the general run of huts during
the dry season, the walls show here and there the scanty beginnings
or the lamentable remains of the mud plastering, and the interior is a
veritable dog-kennel; dirt, dust and disorder everywhere. A few huts
only show any attempt at division into rooms, and this consists
merely of very roughly-made bamboo partitions. In one point alone
have I noticed any indication of progress—in the method of fastening
the door. Houses all over the south are secured in a simple but
ingenious manner. The door consists of a set of stout pieces of wood
or bamboo, tied with bark-string to two cross-pieces, and moving in
two grooves round one of the door-posts, so as to open inwards. If
the owner wishes to leave home, he takes two logs as thick as a man’s
upper arm and about a yard long. One of these is placed obliquely
against the middle of the door from the inside, so as to form an angle
of from 60° to 75° with the ground. He then places the second piece
horizontally across the first, pressing it downward with all his might.
It is kept in place by two strong posts planted in the ground a few
inches inside the door. This fastening is absolutely safe, but of course
cannot be applied to both doors at once, otherwise how could the
owner leave or enter his house? I have not yet succeeded in finding
out how the back door is fastened.